BALA CYNWYD, Pa., March 24, 2022 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (
[email protected]
) or Marc Ackerman (
[email protected]
) at 855-576-4847. There is no cost or financial obligation to you.
Emclaire Financial Corp. (Nasdaq – EMCF)
Under the terms of the agreement, Emclaire will be acquired by Farmers National Banc Corp. (“Farmers”) (Nasdaq – FMNB). Each shareholder of Emclaire may elect to receive either $40.00 per share in cash or 2.15 shares of Farmers’ common stock, subject to an overall limitation of 70% of the shares being exchanged for Farmers’ shares and 30% for cash. Based on Farmers’ closing share price of $17.02 on March 23, 2022, the transaction is valued at approximately $105 million, or $37.62 per share. The investigation concerns whether the Emclaire Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Farmers is paying too little for the Company.
Additional information can be found at
.
Avista Public Acquisition Corp. II (Nasdaq – AHPA)
Under the terms of the agreement, Avista II, a special purpose acquisition company, will combine with OmniAb (“OmniAb”), Ligand Pharmaceuticals Incorporated’s antibody discovery platform which provides pharmaceutical industry partners with access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics, and result in OmniAb becoming a publicly traded company. Under the terms of the agreement, Avista II shareholders will retain ownership of approximately 20.3% of the combined company. The investigation concerns whether the Avista II Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of ownership interest in the combined company.
Additional information can be found at
.
Vectrus, Inc. (NYSE – VEC)
Under the terms of the agreement, Vectrus will be acquired by The Vertex Company (“Vertex”). Vertex shareholders will own approximately 62% of the combined company on a fully diluted basis, while Vectrus shareholders will only own approximately 38%. The investigation concerns whether the Vectrus Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Vertex is paying too little for the Company.
Additional information can be found at
.
Intricon Corporation (Nasdaq – IIN)
Under the terms of the agreement, Intricon will be acquired by an affiliate of Altaris Capital Partners, LLC (collectively with its affiliates, “Altaris”). Intricon shareholders will receive $24.25 in cash for each share of Intricon stock they hold. The investigation concerns whether the Intricon Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Altaris is paying too little for the Company. For example, the deal consideration is below the 52-week high of $28.16 for the Company’s shares.
Additional information can be found at
.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
